Anthony Conway is a seasoned professional in the biopharmaceutical sector, currently serving as Vice President and Head of Research & Development at ProKidney Corp. since February 2025. Prior to this role, Conway held the position of Chief Scientific Officer at Primera Therapeutics for eight months and was instrumental at Replay, where as Vice President and Head of Cell Therapy, contributed to the first IND clearance of PRAME TCR-NK cell therapy. Earlier career milestones include executive roles at Novo Nordisk and Sangamo Therapeutics, where significant advancements in cell therapy and stem cell research were made. Conway holds a Ph.D. in Chemical and Biomolecular Engineering from the University of California, Berkeley, and a Bachelor of Science in Chemical Engineering from the University of Florida.
This person is not in any teams
This person is not in any offices